Roche Holding AG
- Country
- 🇨🇭Switzerland
- Ownership
- Public
- Established
- 1896-01-15
- Employees
- 103.6K
- Market Cap
- $270.5B
- Website
- http://www.roche.com
- Introduction
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.
A Safety and Tolerability Study of Assisted and Self-Administered Subcutaneous (SC) Herceptin (Trastuzumab) as Adjuvant Therapy in Early Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
- First Posted Date
- 2012-03-29
- Last Posted Date
- 2021-04-27
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 2577
- Registration Number
- NCT01566721
- Locations
- 🇩🇴
Hospital Metropolitano de Santiago, Santiago, Dominican Republic
🇫🇷Clinique Tivoli; Sce Radiotherapie, Bordeaux, France
🇪🇨Solca Guayaquil- Sociedad de Lucha Contra El Cáncer; Oncology, Guayaquil, Ecuador
A Study to Assess Efficacy and Safety of Pertuzumab Given in Combination With Trastuzumab and Vinorelbine in Participants With Metastatic or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive Breast Cancer
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2012-03-28
- Last Posted Date
- 2016-11-22
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 213
- Registration Number
- NCT01565083
An Observational Study in Rheumatoid Arthritis Patients Treated With RoActemra/Actemra (Tocilizumab)
- Conditions
- Rheumatoid Arthritis
- First Posted Date
- 2012-03-28
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 51
- Registration Number
- NCT01565122
An Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis Treated With Glucocorticoids
- Conditions
- Rheumatoid Arthritis
- First Posted Date
- 2012-03-28
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 23
- Registration Number
- NCT01564901
A Non-interventional Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis
- First Posted Date
- 2012-03-23
- Last Posted Date
- 2016-11-29
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 50
- Registration Number
- NCT01562327
An Observational Study of MabThera/Rituxan (Rituximab) and Alternative TNF-Inhibitors in Patients With Rheumatoid Arthritis and an Inadequate Response to a Single Previous TNF-Inhibitor
- Conditions
- Rheumatoid Arthritis
- First Posted Date
- 2012-03-19
- Last Posted Date
- 2017-01-24
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 1239
- Registration Number
- NCT01557348
A Single Dose Study of Tamiflu in Volunteers in Dialysis And in Volunteers With Reduced Creatinine Clearance
- First Posted Date
- 2012-03-16
- Last Posted Date
- 2016-07-07
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 16
- Registration Number
- NCT01556633
An Observational Study of Avastin in First Line in Elderly Patients With Metastatic Colorectal Cancer (CASSIOPEE)
- Conditions
- Colorectal Cancer
- First Posted Date
- 2012-03-15
- Last Posted Date
- 2019-03-05
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 402
- Registration Number
- NCT01555762
- Locations
- 🇫🇷
Hopital Victor Jousselin; Gastro Enterologie, Druex, France
🇫🇷Clinique De L Europe; Pmsi, Amiens, France
🇫🇷Centre Hospitalier de L'Agglomeration Montargeoise; Medecine Polyvalente A Orientation Mi & Cancero, Amilly, France
An Global Comparative Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis
- Conditions
- Rheumatoid Arthritis
- First Posted Date
- 2012-03-05
- Last Posted Date
- 2016-02-10
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 1225
- Registration Number
- NCT01543503
A Pharmacodynamic and Pharmacokinetic Study of RO4917838 in Healthy Volunteers
- Conditions
- Healthy Volunteer
- Interventions
- First Posted Date
- 2012-03-05
- Last Posted Date
- 2017-05-10
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 25
- Registration Number
- NCT01543529
- Locations
- 🇫🇷
BIOTRIAL, Rennes, France